As of 2026-03-30, the Fair Value of Rhythm Pharmaceuticals Inc (RYTM) is -14.39 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 75.82 USD, the upside of Rhythm Pharmaceuticals Inc is -118.98%.
With the market price of 75.82 USD and our fair value calculation, Rhythm Pharmaceuticals Inc (RYTM) is not a good investment. Investing in RYTM stocks now will result in a potential loss of 118.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -69.61 | -181.12 | -184.68 | -260.60 | -196.54 | -178.51 |
| YoY growth | 48.05% | -160.19% | -1.96% | -41.11% | 24.58% | -26.13% |
| Market Cap (mil) | 5,177.75 |
| P/E | |
| Forward P/E |
| EPS | -2.88 |
| Avg earnings growth rate | -26.13% |
| TTM earnings | -196.54 |